University of California San Francisco

Yom, S
Sue
Yom
MD, PhD

Associate Professor
Department of Radiation Oncology & Otolaryngology, Head and Neck Surgery

Biography

I am a radiation oncologist who specializes in the treatment of head and neck, lung, and skin cancers. I serve on national guidelines committees outlining the best practices for these cancers. I design clinical trials to improve treatment of these cancers. I give lectures and design courses to help others learn more about how to best treat these cancers. I am a journal editor and interested in publishing the best scientific research on these diseases.

Major research interests include:

- clinical management of head and neck, lung, and skin cancers
- innovations in radiation therapy
- combinations of targeted therapy and immunotherapy with radiation
- virally driven cancers such as HPV, EBV, and Merkel cell polyomavirus
- radiation protectants
- patient-centered decision making
- tobacco cessation
- publication and research ethics

Education

Institution Degree Dept or School End Date
University of California, San Francisco Certificate Diversity, Equity, and Inclusion Champion Training 9/2020
University of California, San Francisco M.A.S. Clinical Research 6/2016
M.D. Anderson Cancer Center Residency Radiation Oncology 6/2007
University of Pennsylvania M.D. School of Medicine 6/2002

Board Certifications

  • American Board of Radiology

Clinical Expertise

Brachytherapy
Bronchioloalveolar Carcinoma (BAC)
Chemoradiation
CyberKnife irradiation for lung and skull base
Electron beam and orthovoltage irradiation
External-beam radiation therapy
Head & Neck Cancer
Hyperthemia
Intensity-modulated radiation therapy
Non-Small Cell Lung Cancer
Small-Cell Lung Cancer

Clinical Trials

  1. Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma (NCT06682442)
    Related Conditions: Nasopharyngeal Cancer, Carcinoma| Start Date: | End Date:
  2. RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer (NCT00956007)
    Related Conditions: Head and Neck Cancer, Head and Neck Tumor| Start Date: | End Date:
  3. Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery (NCT01220583)
    Related Conditions: Head and Neck Cancer| Start Date: | End Date:
  4. A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer (NCT06457503)
    Related Conditions: Nasopharyngeal Cancer| Start Date: | End Date:
  5. Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC) (NCT06097468)
    Related Conditions: Squamous Cell Carcinoma, Carcinoma, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma| Start Date: | End Date:
  6. Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT (NCT06633224)
    Related Conditions: Cancer, General, Thoracic Cancer, Gynecologic Cancer, Head and Neck Cancer, Gastrointestinal Cancer| Start Date: | End Date:
  7. Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer (NCT01302834)
    Related Conditions: Head and Neck Cancer, Cancer, General, Oropharyngeal Cancer, Human Papillomavirus, Oropharynx Cancer| Start Date: | End Date:
  8. Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) (NCT03267498)
    Related Conditions: Nasopharyngeal Cancer, Carcinoma| Start Date: | End Date:
  9. Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy (NCT05273307)
    Related Conditions: Head and Neck Cancer, Taste Dysfunction, Head and Neck Tumor| Start Date: | End Date:
  10. Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer (NCT02254278)
    Related Conditions: Oropharyngeal Cancer, Squamous Cell Carcinoma, Tongue Carcinoma, Head and Neck Cancer, Carcinoma, Head and Neck Squamous Cell Carcinoma| Start Date: | End Date:
  11. Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412) (NCT03040999)
    Related Conditions: Head and Neck Cancer, Head and Neck Tumor, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma, Carcinoma| Start Date: | End Date:
  12. Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer (NCT01236547)
    Related Conditions: Thyroid Cancer, Carcinoma| Start Date: | End Date:
  13. High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery (NCT00533949)
    Related Conditions: Lung Cancer, Radiation Toxicity, Non-Small Cell Lung Cancer, Lung Tumor| Start Date: | End Date:
  14. Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer (NCT03217071)
    Related Conditions: Lung Cancer, Non-Small Cell Lung Cancer, Lung Tumor| Start Date: | End Date:
  15. T-Cell PET Imaging With [18F]F-AraG in Lung Cancer (NCT03311672)
    Related Conditions: Lung Cancer, Non-Small Cell Lung Cancer, Lung Tumor| Start Date: | End Date:
  16. Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma (NCT01835626)
    Related Conditions: Basal Cell Carcinoma, Skin Cancer/Melanoma, Cutaneous Malignancy, Head and Neck Cancer, Carcinoma, Neoplasms| Start Date: | End Date:
  17. National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC (NCT03982459)
    Related Conditions: Lung Cancer, Non-Small Cell Lung Cancer, Lung Tumor| Start Date: | End Date:
  18. Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients (NCT01930435)
    Related Conditions: Head and Neck Cancer, Head and Neck Tumor| Start Date: | End Date:

Program Affiliations

  • Thoracic Oncology Program
  • Head and Neck Oncology Program
  • Visible Tumor and High-Risk Skin Cancer Program
  • Department of Radiation Oncology

Grants and Funding

  • Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients | NIH | 2022-06-13 - 2027-05-31 | Role: Principal Investigator

Research Narrative

In lung cancer, Dr. Yom has conducted research quantifying the risks of pneumonitis and esophagitis when chemotherapy and radiation are given simultaneously. Her research findings were important in establishing the early use of intensity-modulated radiation therapy for lung cancer in combination with 4-dimensional CT-based planning. She has particular expertise in the delivery of chemoradiation therapy for advanced-stage lung cancer, and also the delivery of non-invasive stereotactic CyberKnife radiation for early-stage lung cancer. Her hope is that better understanding of radiation toxicities will permit higher treatment doses, increase the rate of cure and improve patient quality of life. She is strongly committed to research that will lead to more effective, less toxic, and more highly individualized therapy for patients.

Dr. Yom is an investigator on many research studies in head and neck and lung cancer at UCSF, including trials related to to image-guided radiation, head and neck patients' quality of life, and combinations of novel systemic agents with radiation therapy. She is especially interested in improved clinical and translational prognostic models in order to provide more effective and individualized therapy. It is hoped that the reduction of toxicities, both through technical and biologic means, will improve patients' quality of life and potentially enable physicians to deliver more intelligently targeted radiation and chemotherapy doses in search of a better chance of cure. She believes in multidisciplinary management and a unified, team-oriented approach to patient care

Research Interests

  • Head and neck and lung cancers
  • Advanced imaging and radiation planning
  • Radiation in combination with chemotherapy and targeted agents
  • Image-guided and adaptive radiation therapy
  • Radiation sensitizers and protectors
  • Outcomes and quality of life

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 275
  1. Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein-Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma.
    Vasudevan HN, Lazar AA, Reyes K, Rong DA, Arevalo S, Federman S, Chan JW, Chiu CY, Miller S, Yom SS| | PubMed
  2. Dose Planning and Radiation Optimization for Thoracic Conventional, Twice Daily, and Stereotactic Radiation Therapy: A Delphi Consensus from a National Survey of Practitioners.
    Weng J, Ryckman J, Katz MS, Saeed H, Estes C, Naqa IE, Moreno A, Yom SS, Dose Planning and Radiation Optimization (Dose-PRO) Consensus Group| | PubMed
  3. Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial.
    Mell LK, Torres-Saavedra PA, Wong SJ, Kish JA, Chang SS, Jordan RC, Liu T, Truong MT, Winquist EW, Takiar V, Wise-Draper T, Robbins JR, Rodriguez CP, Awan MJ, Beadle BM, Henson C, Narayan S, Spencer SA, Powell S, Dunlap N, Sacco AG, Hu KS, Park HS, Bauman JE, Harris J, Yom SS, Le QT| | PubMed
  4. Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
    Jabbour SK, Higgins KA, Yom SS, Goodman KA| | PubMed
  5. The Top 20 Cited and Downloaded Red Journal Articles of 2023.
    Yom SS| | PubMed
  6. The Lancet Oncology Commission: Radiotherapy & Theranostic Services in LMICs: Minding & Mending the Gaps.
    Momodu JI, Carvajal C, Pryma DA, Anie HA, Michalski JM, Yom SS, Pawlicki T, Corn BW| | PubMed
  7. Reply to M. Boileau et al.
    Barker CA, Yom SS| | PubMed
  8. Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.
    Akaike T, Thakuria M, Silk AW, Hippe DS, Park SY, So NA, Maloney NJ, Gunnell L, Eschholz A, Kim EY, Sinha S, Hall ET, Bhatia S, Reddy S, Rodriguez AA, Aleshin A, Choi JS, Tsai KY, Yom SS, Yu SS, Choi J, Chandra S, Nghiem P, Zaba LC| | PubMed
  9. International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma.
    Li JS, Blanchard P, Wong CHL, Ahn YC, Bonomo P, Bresson D, Caudell J, Chen MY, Chow VLY, Chua MLK, Corry J, Dupin C, Giralt J, Hu CS, Kwong DLW, Le QT, Lee AWM, Lee NY, Li YZ, Lim CM, Lin JC, Mendenhall WM, Moya-Plana A, O'Sullivan B, Ozyar E, Pan JJ, Qiu QH, Sher DJ, Snyderman CH, Tao YG, Tsang RK, Wang XS, Wu PA, Yom SS, Ng WT| | PubMed
  10. Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts.
    Gaudy-Marqueste C, Grob JJ, Garbe C, Ascierto PA, Arron S, Basset-Seguin N, Bohne AS, Lenoir C, Dummer R, Fargnoli MC, Guminski A, Hauschild A, Kaufmann R, Lallas A, Del Marmol V, Migden M, Penicaud M, Rembielak A, Stratigos A, Tagliaferri L, Zalaudek I, Arance A, Badinand D, Bossi P, Challapalli A, Clementi M, Di Stefani A, Ferrándiz-Pulido C, Giuffrida R, Gravina GL, Ha P, Heinzerling L, Mallet S, Paradisi A, Mohr P, Piccerillo A, Rutkowski D, Saiag P, Sollena P, Trakatelli M, Wojcieszek P, Yom SS, Zelin E, Peris K, Malvehy J| | PubMed
  11. Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations.
    Lim AM, McDowell L, Hurt C, Le Tourneau C, Homma A, Shenouda G, Thomson DJ, Moya-Plana A, Henson C, Szturz P, Day AT, Bates JE, Lazarakis S, Thariat J, Psyrri A, Mehanna H, Yom SS, HNCIG| | PubMed
  12. Assessment of endpoint definitions in recurrent and metastatic mucosal head and neck squamous cell carcinoma trials: Head and Neck Cancer International Group consensus recommendations.
    Lim AM, Le Tourneau C, Hurt C, Laskar SG, Steuer CE, Chow VLY, Szturz P, Henson C, Day AT, Bates JE, Lazarakis S, McDowell L, Mehanna H, Yom SS, HNCIG| | PubMed
  13. Criteria for the diagnosis of extranodal extension detected on radiological imaging in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.
    Henson C, Abou-Foul AK, Yu E, Glastonbury C, Huang SH, King AD, Lydiatt WM, McDowell L, Nagelschneider AA, Nankivell PC, O'Sullivan B, Rhys R, Xiao Y, Andrew D, Asmussen JT, Bidault F, Dankbaar JW, de Graaf P, Gebrim ES, Hu C, Ding J, Kanda T, Kim J, Kuno H, Medrano-Martorell S, Oikonomopoulos N, Goh JP, Santos-Armentia E, Schafigh DG, Subramaniam RM, Wu XC, Yom SS, Mehanna H| | PubMed
  14. Standardised definitions and diagnostic criteria for extranodal extension detected on histopathological examination in head and neck cancer: Head and Neck Cancer International Group consensus recommendations.
    Abou-Foul AK, Henson C, Chernock RD, Huang SH, Lydiatt WM, McDowell L, O'Sullivan B, Perez-Ordonez B, Robinson M, Nankivell PC, Ruiz-Bravo E, Chiosea SI, Green TM, Hunter KD, Hwang JS, Koljenovic S, Koppes SA, Larsen SR, Lo AWI, Costes-Martineau V, Mittal N, Mori T, Nagao T, Panayiotides IG, Pinto CAL, Scheckenbach K, Seethala RR, Ulhøi BP, Vingiani A, Zhang Y, Yom SS, Mehanna H| | PubMed
  15. 68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG.
    Kline B, Yadav S, Seo Y, Ippisch RC, Castillo J, Aggarwal RR, Kelley RK, Behr SC, Flavell RR, Lawhn-Heath C, Melisko M, Rugo HS, Wang V, Yom SS, Ha P, Jiang F, Hope TA| | PubMed
  16. Quantification of the environmental impact of radiotherapy and associated secondary human health effects: a multi-institutional retrospective analysis and simulation.
    Lichter KE, Charbonneau K, Lewy JR, Bloom JR, Shenker R, Sabbagh A, Chino J, Rodrigues A, Hearn J, Grover S, Sheu RD, Witztum A, Qureshi MM, Yom SS, Anand C, Thiel CL, Mohamad O| | PubMed
  17. Association of a 40-Gene Expression Profile With Risk of Metastatic Disease Progression of Cutaneous Squamous Cell Carcinoma and Specification of Benefit of Adjuvant Radiation Therapy.
    Arron ST, Cañueto J, Siegel J, Fitzgerald A, Prasai A, Koyfman SA, Yom SS| | PubMed
  18. A Hard Truth to Swallow: Critically Evaluating the MD Anderson Dysphagia Inventory (MDADI) as an Endpoint in Human Papillomavirus-associated Oropharyngeal Cancer Trials.
    McDowell L, King MT, Hutcheson KA, Ringash J, Yom SS, Corry J, Henson C, Mehanna H, Rischin D| | PubMed
  19. Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma.
    Barker CA, Dufault S, Arron ST, Ho AL, Algazi AP, Dunn LA, Humphries AA, Hultman C, Lian M, Knott PD, Yom SS| | PubMed
  20. Assessing the knowledge and awareness of US oncologists regarding the specialty of oral medicine.
    Aljishi M, Yom SS, Shiboski CH, Villa A| | PubMed
  21. International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers.
    Liem X, de Baère T, Vivar OI, Seiwert TY, Shen C, Pápai Z, Moreno V, Takácsi-Nagy Z, Helfferich F, Thariat J, Gooi Z, Yom SS, Bossi P, Ferris RL, Hackman TG, Le Tourneau C, Rodriguez J, Hoffmann C| | PubMed
  22. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database.
    Baliga S, Abou-Foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Blakaj D, Brennan S, Brunet A, De Oliveira TB, Burtness B, Maseda AC, Chow VL, Chua ML, de Ridder M, Garikipati S, Hanai N, Ho FCH, Huang SH, Kiyota N, Klinghammer K, Kowalski LP, Kwong DL, McDowell LJ, Merlano MC, Nair S, Economopoulou P, Overgaard J, Psyrri A, Tribius S, Waldron J, Yom SS, Mehanna H| | PubMed
  23. Higher area deprivation index is associated with poorer local control and overall survival in non-metastatic nasopharyngeal carcinoma.
    Malik NH, Montero M, Chen JJ, Sinha S, Yom SS, Chan JW| | PubMed
  24. Combinatorial Therapies: Embracing Our Multifaceted Future.
    Jabbour SK, Yom SS| | PubMed
  25. Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center.
    Keenan BP, Sibley A, Zhang L, Westring AF, Velazquez AI, Bank EM, Bergsland EK, Boreta L, Conroy P, Daras M, Hermiston M, Hsu G, Paris PL, Piawah S, Sinha S, Sosa JA, Tsang M, Venook AP, Wong M, Yom SS, Van Loon K| | PubMed
  26. Combinatorial Approaches for Chemotherapies and Targeted Therapies With Radiation: United Efforts to Innovate in Patient Care.
    Jabbour SK, Kumar R, Anderson B, Chino JP, Jethwa KR, McDowell L, Lo AC, Owen D, Pollom EL, Tree AC, Tsang DS, Yom SS| | PubMed
  27. Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design.
    Ferris RL, Mehanna H, Schoenfeld JD, Tahara M, Yom SS, Haddad R, König A, Witzler P, Bajars M, Tourneau CL| | PubMed
  28. Evaluating the Hounsfield unit assignment and dose differences between CT-based standard and deep learning-based synthetic CT images for MRI-only radiation therapy of the head and neck.
    Singhrao K, Dugan CL, Calvin C, Pelayo L, Yom SS, Chan JW, Scholey JE, Singer L| | PubMed
  29. Incidental findings and safety events from magnetic resonance imaging simulation for head and neck radiation treatment planning: A single institution experience.
    Massachi J, Singer L, Glastonbury C, Scholey J, Singhrao K, Calvin C, Yom SS, Chan JW| | PubMed
  30. Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
    Limkin E, Blanchard P, Lacas B, Bourhis J, Parmar M, Licitra L, Le QT, Yom SS, Fortpied C, Langendijk J, Vermorken JB, Bernier J, Overgaard J, Harris J, Pignon JP, Auperin A, MACH-NC* and MARCH** collaborative groups| | PubMed
  31. Elective management of the N0 neck in maxillary sinus squamous cell carcinoma.
    Patel EJ, Strohl MP, Yom SS, El-Sayed I| | PubMed
  32. ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer.
    Expert Panel on Neurological Imaging, Gule-Monroe MK, Calle S, Policeni B, Juliano AF, Agarwal M, Chow LQM, Dubey P, Friedman ER, Hagiwara M, Hanrahan KD, Jain V, Rath TJ, Smith RB, Subramaniam RM, Taheri MR, Yom SS, Zander D, Burns J| | PubMed
  33. Treatment Delays in Oral Cavity Cancer-Time, Time, Time, See What's Become of Me.
    Graboyes EM, Yom SS| | PubMed
  34. Effects of Wildfire Events on California Radiation Oncology Clinics and Patients.
    Lichter KE, Baniel CC, Do I, Medhat Y, Avula V, Nogueira LM, Bates JE, Paulsson A, Malik N, Hiatt RA, Yom SS, Mohamad O| | PubMed
  35. Treatment Modality Impact on Patient-Reported Quality of Life in Human Papilloma Virus-Associated Oropharyngeal Carcinoma.
    Plonowska-Hirschfeld KA, Gulati A, Stephens EM, Ochoa E, Xu MJ, Ha PK, Heaton CM, Yom SS, Chan JW, Algazi A, Kang H, Ryan WR| | PubMed
  36. High-Quality Science and the People Who Make It: Red Journal Outstanding Reviewers of 2022.
    Yom SS| | PubMed
  37. The Top 20 Cited and Downloaded Red Journal Articles of 2022.
    Yom SS| | PubMed
  38. Promoting Women and Historically Excluded Minorities in Medicine as Essential Leaders of Research.
    Iheagwara UK, Patel S, Diaz DA, Yom SS, Goodman KA, Barry PN| | PubMed
  39. Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer.
    Mayo CS, Feng MU, Brock KK, Kudner R, Balter P, Buchsbaum JC, Caissie A, Covington E, Daugherty EC, Dekker AL, Fuller CD, Hallstrom AL, Hong DS, Hong JC, Kamran SC, Katsoulakis E, Kildea J, Krauze AV, Kruse JJ, McNutt T, Mierzwa M, Moreno A, Palta JR, Popple R, Purdie TG, Richardson S, Sharp GC, Satomi S, Tarbox LR, Venkatesan AM, Witztum A, Woods KE, Yao Y, Farahani K, Aneja S, Gabriel PE, Hadjiiski L, Ruan D, Siewerdsen JH, Bratt S, Casagni M, Chen S, Christodouleas JC, DiDonato A, Hayman J, Kapoor R, Kravitz S, Sebastian S, Von Siebenthal M, Bosch W, Hurkmans C, Yom SS, Xiao Y| | PubMed
  40. A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer.
    Gulati A, Plonowska-Hirschfeld K, Stephens EM, Kansara S, Zebolsky AL, Ochoa E, Xu MJ, Ha PK, Heaton CM, Yom SS, Chan JW, Algazi AP, Kang H, Ryan WR| | PubMed
  41. Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
    Garden AS, Harris J, Eisbruch A, Chao KSC, Morrison WH, Harari PM, Swanson TA, Jones CU, Yom SS, Spencer SA, Scrimger R, Shenouda G, Shukla M, Lau HY, Mierzwa M, Torres-Saavedra P, Le QT| | PubMed
  42. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.
    Sherman EJ, Harris J, Bible KC, Xia P, Ghossein RA, Chung CH, Riaz N, Gunn GB, Foote RL, Yom SS, Wong SJ, Koyfman SA, Dzeda MF, Clump DA, Khan SA, Shah MH, Redmond K, Torres-Saavedra PA, Le QT, Lee NY| | PubMed
  43. Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
    Rodriguez CP, Kang H, Geiger JL, Burtness B, Chung CH, Pickering CR, Fakhry C, Le QT, Yom SS, Galloway TJ, Golemis E, Li A, Shoop J, Wong S, Mehra R, Skinner H, Saba NF, Flores ER, Myers JN, Ford JM, Karchin R, Ferris RL, Kunos C, Lynn JM, Malik S| | PubMed
  44. Tinkering With the Fit.
    Yom SS| | PubMed
  45. The Oligometastatic State: Balancing Between Cure and Palliation.
    Jabbour SK, Yom SS| | PubMed
  46. 18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002.
    Subramaniam RM, DeMora L, Yao M, Yom SS, Gillison M, Caudell JJ, Waldron J, Xia P, Chung CH, Truong MT, Echevarria M, Chan JW, Geiger JL, Mell L, Seaward S, Thorstad WL, Beitler JJ, Sultanem K, Blakaj D, Le QT| | PubMed
  47. Environmental Outcomes Associated With Transition From In-Person to a Virtual Oncology Conference During the COVID-19 Pandemic.
    Lichter KE, Drew T, Demeulenaere S, Wong E, Mohamad O, Yom SS, Bagshaw HP| | PubMed
  48. The Top Circulated Red Journal Articles From 2021: Views, Citations, Tweets, Downloads, and Shares.
    Yom SS| | PubMed
  49. Longitudinal Analysis of Swallowing Displacement Kinematics After Oropharyngeal Cancer Treatment.
    Kidane J, Laus J, Gulati A, Gochman GE, Schneider SL, Chan JW, Yom SS, Ha P, Boscardin WJ, Ryan WR, Ma Y| | PubMed
  50. Feasibility of accelerated image-guided high-dose-rate interstitial brachytherapy with inverse planning simulated annealing (IPSA-HDRBT) for post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongue.
    Cheung CK, Chew J, Wai K, Calkins SM, Ha PK, Ryan WR, Cunha A, Yom SS, Hsu IC, Chan JW| | PubMed
  51. Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Pa
    Katsoulakis E, Kudner R, Chapman C, Park J, Puckett L, Solanki A, Kapoor R, Hagan M, Kelly M, Palta J, Tishler R, Hitchcock Y, Chera B, Feygelman V, Walker G, Sher D, Kujundzic K, Wilson E, Dawes S, Yom SS, Harrison L| | PubMed
  52. Head and neck cancer: high-end technology is no guarantee of high-quality care - Authors' reply.
    Saba NF, Mody MD, Rocco JW, Haddad RI, Yom SS| | PubMed
  53. Diving into the Wreck: To Search for the Thing Itself.
    Yom SS| | PubMed
  54. The Red Journal Outstanding Reviewer Awards for 2021.
    Yom SS| | PubMed
  55. Improved accuracy of relative electron density and proton stopping power ratio through CycleGAN machine learning.
    Scholey J, Vinas L, Kearney V, Yom S, Larson PEZ, Descovich M, Sudhyadhom A| | PubMed
  56. Evaluating the Generalizability and Reproducibility of Scientific Research.
    Yom SS, Deville C, Boerma M, Carlson D, Jabbour SK, Braverman L| | PubMed
  57. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria.
    Ward MC, Koyfman SA, Bakst RL, Margalit DN, Beadle BM, Beitler JJ, Chang SS, Cooper JS, Galloway TJ, Ridge JA, Robbins JR, Sacco AG, Tsai CJ, Yom SS, Siddiqui F| | PubMed
  58. Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.
    Guix I, Liu Q, Pujana MA, Ha P, Piulats J, Linares I, Guedea F, Mao JH, Lazar A, Chapman J, Yom SS, Ashworth A, Barcellos-Hoff MH| | PubMed
  59. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.
    Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, Colevas AD, Eisele DW, Galloway T, Geiger JL, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Mell LK, Mittal BB, Pinto HA, Rocco JW, Rodriguez CP, Savvides PS, Schwartz D, Shah JP, Sher D, St John M, Weber RS, Weinstein G, Worden F, Yang Bruce J, Yom SS, Zhen W, Burns JL, Darlow SD| | PubMed
  60. International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma.
    Beddok A, Guzene L, Coutte A, Thomson D, Yom SS, Calugaru V, Blais E, Gilliot O, Racadot S, Pointreau Y, Corry J, Jensen K, Porceddu S, Khalladi N, Bastit V, Lasne-Cardon A, Marcy PY, Carsuzaa F, Nioche C, Bourhis J, Salleron J, Thariat J, GORTEC| | PubMed
  61. Endings and Beginnings, and What Twists and Turns Could Lie on the Road Ahead.
    Yom SS| | PubMed
  62. Artificial Intelligence-Guided Prediction of Dental Doses Before Planning of Radiation Therapy for Oropharyngeal Cancer: Technical Development and Initial Feasibility of Implementation.
    Chan JW, Hohenstein N, Carpenter C, Pattison AJ, Morin O, Valdes G, Sanchez CT, Perkins J, Solberg TD, Yom SS| | PubMed
  63. Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck.
    Rodriguez-Russo CA, Junn JC, Yom SS, Bakst RL| | PubMed
  64. Promoting Gender Equity at the Red Journal: A Decade's Work.
    Campbell SR, Bennett KE, Yom SS, Jagsi R| | PubMed
  65. Right on the Nose: A Case of Locally Invasive Extranodal Lymphoma.
    Thomas HR, Yom SS| | PubMed
  66. Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial-based therapeutics.
    Radaic A, Ganther S, Kamarajan P, Grandis J, Yom SS, Kapila YL| | PubMed
  67. Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.
    Lee RH, Kang H, Yom SS, Smogorzewska A, Johnson DE, Grandis JR| | PubMed
  68. Head and neck cancer.
    Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF| | PubMed
  69. Should Sentinel Lymph Node Biopsy Status Guide Adjuvant Radiation Therapy in Patients With Merkel Cell Carcinoma?
    Ahmad TR, Vasudevan HN, Lazar AA, Chan JW, George JR, Alvarado MD, Yu SS, Daud A, Yom SS| | PubMed
  70. An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication.
    Morin O, Vallières M, Braunstein S, Ginart JB, Upadhaya T, Woodruff HC, Zwanenburg A, Chatterjee A, Villanueva-Meyer JE, Valdes G, Chen W, Hong JC, Yom SS, Solberg TD, Löck S, Seuntjens J, Park C, Lambin P| | PubMed
  71. Nasopharyngeal Carcinoma and Its Association with Epstein-Barr Virus.
    Vasudevan HN, Yom SS| | PubMed
  72. Reply to A. J. Cmelak et al and B. Kalra et al.
    Yom SS, Torres-Saavedra PA, Le QT| | PubMed
  73. Can Sex and Seniority Predict the Quality of a Journal Reviewer's Manuscript Critique?
    Jamorabo DS, Deek MP, Yom SS, Rehman H, Zietman AL, Motwani SB, Briggs WM, Kim S, Chang DT, Jabbour SK| | PubMed
  74. Doc, I feel tired… oh really, so how's your mucositis?
    Kober KM, Yom SS| | PubMed
  75. Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: A GORTEC internationally-reviewed HNCIG-endorsed consensus.
    Carsuzaa F, Lapeyre M, Gregoire V, Maingon P, Beddok A, Marcy PY, Salleron J, Coutte A, Racadot S, Pointreau Y, Graff P, Beadle B, Benezery K, Biau J, Calugaru V, Castelli J, Chua M, Di Rito A, Dore M, Ghadjar P, Huguet F, Jardel P, Johansen J, Kimple R, Krengli M, Laskar S, Mcdowell L, Nichols A, Tribius S, Valduvieco I, Hu C, Liem X, Moya-Plana A, D'onofrio I, Parvathaneni U, Takiar V, Orlandi E, Psyrri A, Shenouda G, Sher D, Steuer C, Shan Sun X, Tao Y, Thomson D, Tsai MH, Vulquin N, Gorphe P, Mehanna H, Yom SS, Bourhis J, Thariat J| | PubMed
  76. The Red Journal's Top Downloaded Articles in 2020.
    Zietman AL, Yom SS| | PubMed
  77. The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.
    Kish JA, Zhang Q, Langer CJ, Nguyen-Tân PF, Rosenthal DI, Weber RS, List MA, Wong SJ, Garden AS, Hu K, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad W, Schultz CJ, Ridge JA, Shenouda G, Harris J, Le QT| | PubMed
  78. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma.
    Ng WT, Soong YL, Ahn YC, AlHussain H, Choi HCW, Corry J, Grégoire V, Harrington KJ, Hu CS, Jensen K, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Pan JJ, Peters LJ, Poh SS, Rosenthal DI, Sanguineti G, Tao Y, Wee JT, Yom SS, Chua MLK, Lee AWM| | PubMed
  79. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
    Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, Truong MT, Kong C, Jordan R, Subramaniam RM, Yao M, Chung CH, Geiger JL, Chan JW, O'Sullivan B, Blakaj DM, Mell LK, Thorstad WL, Jones CU, Banerjee RN, Lominska C, Le QT| | PubMed
  80. Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.
    Chen YP, Ismaila N, Chua MLK, Colevas AD, Haddad R, Huang SH, Wee JTS, Whitley AC, Yi JL, Yom SS, Chan ATC, Hu CS, Lang JY, Le QT, Lee AWM, Lee N, Lin JC, Ma B, Morgan TJ, Shah J, Sun Y, Ma J| | PubMed
  81. Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.
    Margalit DN, Sacco AG, Cooper JS, Ridge JA, Bakst RL, Beadle BM, Beitler JJ, Chang SS, Chen AM, Galloway TJ, Koyfman SA, Mita C, Robbins JR, Tsai CJ, Truong MT, Yom SS, Siddiqui F| | PubMed
  82. Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study.
    Lawhn-Heath C, Yom SS, Liu C, Villanueva-Meyer JE, Aslam M, Smith R, Narwal M, Juarez R, Behr SC, Pampaloni MH, Chan JW, Glastonbury CM, Hope TA, Flavell RR| | PubMed
  83. Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary.
    Tsai CJ, Galloway TJ, Margalit DN, Bakst RL, Beadle BM, Beitler JJ, Chang S, Chen A, Cooper J, Koyfman SA, Ridge JA, Robbins J, Truong MT, Yom SS, Siddiqui F| | PubMed
  84. Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology.
    Gensheimer MF, Yom SS, Soto N, Dignam JJ, Le QT, Machtay M, Curran WJ| | PubMed
  85. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
    Wu SY, Lazar AA, Gubens MA, Blakely CM, Gottschalk AR, Jablons DM, Jahan TM, Wang VEH, Dunbar TL, Wong ML, Chan JW, Guthrie W, Belkora J, Yom SS| | PubMed
  86. Radiation Therapy and the Immune System: A Scientific Revolution in the Making.
    Zietman AL, Yom SS| | PubMed
  87. Trends in Financial Relationships Between Industry and Radiation Oncologists Versus Other Physicians in the United States from 2014 to 2018.
    Marshall DC, Tarras ES, Rosenzweig K, Yom SS, Hattangadi-Gluth J, Murphy J, Korenstein D, Chimonas S| | PubMed
  88. Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development.
    Thomson DJ, Yom SS, Saeed H, El Naqa I, Ballas L, Bentzen SM, Chao ST, Choudhury A, Coles CE, Dover L, Guadagnolo BA, Guckenberger M, Hoskin P, Jabbour SK, Katz MS, Mukherjee S, Rembielak A, Sebag-Montefiore D, Sher DJ, Terezakis SA, Thomas TV, Vogel J, Estes C| | PubMed
  89. Imagining Our Lives Post-Pandemic.
    Yom SS, Zietman AL| | PubMed
  90. PET/CT in Surgical Planning for Head and Neck Cancer.
    Strohl MP, Ha PK, Flavell RR, Yom SS| | PubMed
  91. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement.
    Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SS| | PubMed
  92. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement.
    Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D| | PubMed
  93. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
    Park S, Vora M, van Zante A, Humtsoe J, Kim HS, Yom S, Agarwal S, Ha P| | PubMed
  94. DoseGAN: a generative adversarial network for synthetic dose prediction using attention-gated discrimination and generation.
    Kearney V, Chan JW, Wang T, Perry A, Descovich M, Morin O, Yom SS, Solberg TD| | PubMed
  95. Combining Systemic Therapy With Radiation: Head and Neck Cancer Treatments in an Era of Targeted Agents and Immunotherapy.
    Vasudevan HN, Yom SS| | PubMed
  96. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
    Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco JW, Rodriguez CP, Shah JP, Weber RS, Weinstein G, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD| | PubMed
  97. Is It Worth It? Consequences of Definitive Head and Neck Reirradiation.
    Foster CC, Fan M, Lee NY, Yom SS, Heaton CM, Deraniyagala R, Amdur R, Weichselbaum RR, Haraf DJ| | PubMed
  98. Understanding Response to Immunotherapy Using Standard of Care and Experimental Imaging Approaches.
    Flavell RR, Evans MJ, Villanueva-Meyer JE, Yom SS| | PubMed
  99. Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus.
    Mehanna H, Hardman JC, Shenson JA, Abou-Foul AK, Topf MC, AlFalasi M, Chan JYK, Chaturvedi P, Chow VLY, Dietz A, Fagan JJ, Godballe C, Golusinski W, Homma A, Hosal S, Iyer NG, Kerawala C, Koh YW, Konney A, Kowalski LP, Kraus D, Kuriakose MA, Kyrodimos E, Lai SY, Leemans CR, Lennon P, Licitra L, Lou PJ, Lyons B, Mirghani H, Nichols AC, Paleri V, Panizza BJ, Parente Arias P, Patel MR, Piazza C, Rischin D, Sanabria A, Takes RP, Thomson DJ, Uppaluri R, Wang Y, Yom SS, Zhu YM, Porceddu SV, de Almeida JR, Simon C, Holsinger FC| | PubMed
  100. Dental intervention for the irradiated patient: time to re-evaluate dental treatment algorithms?
    Rosen EB, Ahmed ZU, Randazzo JD, Yom S, Estilo CL, Huryn JM| | PubMed
  101. In Reply to Gupta et al.
    Thomson DJ, Yom SS| | PubMed
  102. Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
    Chang CF, Ei-Sayed IH, George JR, Heaton CM, Ryan WR, Susko MS, Yom SS, Ha PK| | PubMed
  103. Improved Tumor Control Related to Radiotherapy Technological Development for Hypopharyngeal Cancer.
    Susko MS, Lazar AA, Dhar S, Chan JW, Shiao SL, Chapman CH, Johnson J, Quivey JM, Ryan WR, Heaton CM, Ha PK, Yom SS| | PubMed
  104. Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.
    Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SS| | PubMed
  105. Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the Delivery of Postoperative Radiation Therapy in Complex Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN).
    Porceddu SV, Daniels C, Yom SS, Liu H, Waldron J, Gregoire V, Moore A, Veness M, Yao M, Johansen J, Mehanna H, Rischin D, Le QT| | PubMed
  106. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
    Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D| | PubMed
  107. Outcomes of sinonasal mucosal melanomas with endoscopic and open resection: a retrospective cohort study.
    Almutuawa DM, Strohl MP, Gruss C, van Zante A, Yom SS, McDermott MW, El-Sayed IH| | PubMed
  108. Attention-Aware Discrimination for MR-to-CT Image Translation Using Cycle-Consistent Generative Adversarial Networks.
    Kearney V, Ziemer BP, Perry A, Wang T, Chan JW, Ma L, Morin O, Yom SS, Solberg TD| | PubMed
  109. Comments on the Publication by Corkum et al on "Does 5 + 5 mm Equal Better Radiation Treatment Plans in Head and Neck Cancers?"
    Grégoire V, Grau C, Le QT, Yom SS, Head and Neck Intergroup| | PubMed
  110. Diagnosis, Staging, Radiation Treatment Response Assessment, and Outcome Prognostication of Head and Neck Cancers Using PET Imaging: A Systematic Review.
    Hohenstein NA, Chan JW, Wu SY, Tahir P, Yom SS| | PubMed
  111. Current Standards for Organ Preservation in Locoregionally Advanced Non-nasopharyngeal Head and Neck Cancer and Evolving Strategies for Favorable-Risk and Platinum-Ineligible Populations.
    Wu SY, Yom SS| | PubMed
  112. Locally advanced non-melanomatous skin cancer: Contemporary radiotherapeutic management.
    McDowell L, Yom SS| | PubMed
  113. Statement From the Editors.
    Zietman AL, Yom SS| | PubMed
  114. ASTRO Journals' Data Sharing Policy and Recommended Best Practices.
    Tegbaru D, Braverman L, Zietman AL, Yom SS, Lee WR, Miller RC, Jackson IL, McNutt T, Dekker A| | PubMed
  115. Changing functional status within 6 months posttreatment is prognostic of overall survival in patients with head and neck cancer: NRG Oncology Study.
    Eldridge RC, Pugh SL, Trotti A, Hu K, Spencer S, Yom SS, Rosenthal D, Read N, Desai A, Gore E, Shenouda G, Mishra MV, Bruner D, Xiao C| | PubMed
  116. Management of locally recurrent nasopharyngeal carcinoma.
    Lee AWM, Ng WT, Chan JYW, Corry J, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, Suárez C, Vermorken JB, Yom SS, Ferlito A| | PubMed
  117. Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.
    Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT| | PubMed
  118. Attention-enabled 3D boosted convolutional neural networks for semantic CT segmentation using deep supervision.
    Kearney V, Chan JW, Wang T, Perry A, Yom SS, Solberg TD| | PubMed
  119. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma.
    Lee AW, Ng WT, Pan JJ, Chiang CL, Poh SS, Choi HC, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Sanguineti G, Soong YL, Tao Y, Yom SS, Wee JT| | PubMed
  120. Think Carefully, Publish Safely: Co-Authorship and Conflict of Interest Verification in the ASTRO Journals.
    Braverman LC, Yom SS, Zietman AL| | PubMed
  121. Can Early Dental Extractions Reduce Delays in Postoperative Radiation for Patients With Advanced Oral Cavity Carcinoma?
    Strohl MP, Chen JP, Ha PK, Seth R, Yom SS, Heaton CM| | PubMed
  122. Dedicated Diagnostic Radiology/Radiation Oncology Rounds: Added Value Beyond Traditional Tumor Boards.
    Kallianos KG, Muhoozi BN, Gottschalk A, Yom SS, Chan JW, Henry TS, Elicker BM, Ordovas KG, Naeger DM| | PubMed
  123. The Red Journal's Outstanding Reviewers of 2018.
    Zietman AL, Yom SS| | PubMed
  124. ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer.
    Expert Panel on Thoracic Imaging:, de Groot PM, Chung JH, Ackman JB, Berry MF, Carter BW, Colletti PM, Hobbs SB, McComb BL, Movsas B, Tong BC, Walker CM, Yom SS, Kanne JP| | PubMed
  125. Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients.
    Gay HA, Santiago R, Gil B, Remedios C, Montes PJ, López-Araujo J, Chévere CM, Imbert WS, White J, Arthur DW, Horton JK, Jagsi R, Rabinovich R, Beriwal S, Viswanathan A, Erickson BA, Rengan R, Palma D, Loo BW, Kavanaugh JA, Bradley J, Yom SS, Harari PM, Lee Burnett O| | PubMed
  126. A convolutional neural network algorithm for automatic segmentation of head and neck organs at risk using deep lifelong learning.
    Chan JW, Kearney V, Haaf S, Wu S, Bogdanov M, Reddick M, Dixit N, Sudhyadhom A, Chen J, Yom SS, Solberg TD| | PubMed
  127. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L, Chin RI, Gastman B, Thorstad W, Yom SS, Reddy CA, Nussenbaum B, Wang SJ, Knackstedt T, Vidimos AT, Koyfman SA, Manyam BV| | PubMed
  128. Integrating the Management of Nodal Metastasis Into the Treatment of Nonmelanoma Skin Cancer.
    Yom SS| | PubMed
  129. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer.
    Xu MJ, Plonowska KA, Gurman ZR, Humphrey AK, Ha PK, Wang SJ, El-Sayed IH, Heaton CM, George JR, Yom SS, Algazi AP, Ryan WR| | PubMed
  130. Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.
    Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT| | PubMed
  131. Jim Cox-The Passing of an Era.
    Yom SS, Zietman AL| | PubMed
  132. Making Sure Retractions Matter.
    Zietman AL, Yom SS, Braverman LC| | PubMed
  133. Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.
    Koyfman SA, Ismaila N, Crook D, D'Cruz A, Rodriguez CP, Sher DJ, Silbermins D, Sturgis EM, Tsue TT, Weiss J, Yom SS, Holsinger FC| | PubMed
  134. Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.
    Chan JW, Yeh I, El-Sayed IH, Algazi AP, Glastonbury CM, Ha PK, Yom SS, van Zante A| | PubMed
  135. Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning: An ASTRO Consensus Paper.
    Wright JL, Yom SS, Awan MJ, Dawes S, Fischer-Valuck B, Kudner R, Mailhot Vega R, Rodrigues G| | PubMed
  136. Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer.
    Bakst RL, Glastonbury CM, Parvathaneni U, Katabi N, Hu KS, Yom SS| | PubMed
  137. Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.
    Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, Gopaul DD, Gomez Suescun JB, McGarry RC, Choy H, Bradley JD| | PubMed
  138. In Regard to Bossi et al.
    Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT| | PubMed
  139. The application of artificial intelligence in the IMRT planning process for head and neck cancer.
    Kearney V, Chan JW, Valdes G, Solberg TD, Yom SS| | PubMed
  140. Seeing What's Before Us: Imaging in the Electronic Age.
    Brock KK, Yom SS| | PubMed
  141. A Deep Look Into the Future of Quantitative Imaging in Oncology: A Statement of Working Principles and Proposal for Change.
    Morin O, Vallières M, Jochems A, Woodruff HC, Valdes G, Braunstein SE, Wildberger JE, Villanueva-Meyer JE, Kearney V, Yom SS, Solberg TD, Lambin P| | PubMed
  142. In Regard to Beadle and Anderson.
    Le QT, Yom SS, Wee JTS, Lee AWM, Grau C, Grégoire V, Porceddu S, Welch JJ, Mehanna H| | PubMed
  143. Red Journal Readers' Top Articles From 2017.
    Yom SS, Zietman AL| | PubMed
  144. In the Eye of the Maximal Storm: Surgery Versus Radiation?
    Janopaul-Naylor J, Yom SS| | PubMed
  145. In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series.
    Xu MJ, Wu S, Daud AI, Yu SS, Yom SS| | PubMed
  146. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
    Winchester D, Lehman J, Tello T, Chimato N, Hocker T, Kim S, Chang J, Markey J, Yom SS, Ryan W, Mully T, Hodge D, Otley C, Arron ST| | PubMed
  147. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.
    Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD| | PubMed
  148. Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy.
    Chapman CH, McGuinness C, Gottschalk AR, Yom SS, Garsa AA, Anwar M, Braunstein SE, Sudhyadhom A, Keall P, Descovich M| | PubMed
  149. Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma.
    Xu MJ, Wu TJ, van Zante A, El-Sayed IH, Algazi AP, Ryan WR, Ha PK, Yom SS| | PubMed
  150. Submandibular Gland Transfer: A Potential Imaging Pitfall.
    Wu X, Yom SS, Ha PK, Heaton CM, Glastonbury CM| | PubMed
  151. Radiation Therapy in a Time of Disaster.
    Yom SS, Zietman AL| | PubMed
  152. When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer Patients.
    Yom SS, Harari PM| | PubMed
  153. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy.
    Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-Sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS| | PubMed
  154. Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension.
    Yu Y, El-Sayed IH, McDermott MW, Theodosopoulos PV, van Zante A, Kased N, Glastonbury CM, Garsa AA, Yom SS| | PubMed
  155. American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology.
    Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI| | PubMed
  156. Merkel cell carcinoma: An update and review: Current and future therapy.
    Tello TL, Coggshall K, Yom SS, Yu SS| | PubMed
  157. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.
    Zhou MJ, van Zante A, Lazar AA, Groppo ER, Garsa AA, Ryan WR, El-Sayed IH, Eisele DW, Yom SS| | PubMed
  158. In Reply to Zoto Mustafayev and Ozyar.
    Le QT, Yom SS, Ng RHW, Bratman SV, Welch JJ, Chan KCA, Kim KY| | PubMed
  159. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncolog
    Grégoire V, Evans M, Le QT, Bourhis J, Budach V, Chen A, Eisbruch A, Feng M, Giralt J, Gupta T, Hamoir M, Helito JK, Hu C, Hunter K, Johansen J, Kaanders J, Laskar SG, Lee A, Maingon P, Mäkitie A, Micciche' F, Nicolai P, O'Sullivan B, Poitevin A, Porceddu S, Skladowski K, Tribius S, Waldron J, Wee J, Yao M, Yom SS, Zimmermann F, Grau C| | PubMed
  160. Clinical decision support of radiotherapy treatment planning: A data-driven machine learning strategy for patient-specific dosimetric decision making.
    Valdes G, Simone CB, Chen J, Lin A, Yom SS, Pattison AJ, Carpenter CM, Solberg TD| | PubMed
  161. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.
    Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H, Corry J, Grau C, Grégoire V, Harrington KJ, Hu CS, Kwong DL, Langendijk JA, Le QT, Lee NY, Lin JC, Lu TX, Mendenhall WM, O'Sullivan B, Ozyar E, Peters LJ, Rosenthal DI, Soong YL, Tao Y, Yom SS, Wee JT| | PubMed
  162. Medical marijuana for the treatment of vismodegib-related muscle spasm.
    Yuan JT, Tello TL, Hultman C, Barker CA, Arron ST, Yom SS| | PubMed
  163. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
    Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML| | PubMed
  164. Clinical Research Ethics: Considerations for the Radiation Oncologist.
    Koyfman SA, Yom SS| | PubMed
  165. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
    Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD| | PubMed
  166. Controversies in Postoperative Irradiation of Oropharyngeal Cancer After Transoral Surgery.
    Yom SS, Mallen-St Clair J, Ha PK| | PubMed
  167. Validating Dose Uncertainty Estimates Produced by AUTODIRECT: An Automated Program to Evaluate Deformable Image Registration Accuracy.
    Kim H, Chen J, Phillips J, Pukala J, Yom SS, Kirby N| | PubMed
  168. Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer.
    Kim KY, Le QT, Yom SS, Pinsky BA, Bratman SV, Ng RH, El Mubarak HS, Chan KC, Sander M, Conley BA| | PubMed
  169. A feasibility and efficacy trial of a hand-held humidification device in patients undergoing radiotherapy for head and neck cancer.
    Ghosh P, Lazar AA, Ryan WR, Yom SS| | PubMed
  170. Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients.
    Kim KY, Le QT, Yom SS, Ng RHW, Chan KCA, Bratman SV, Welch JJ, Divi RL, Petryshyn RA, Conley BA| | PubMed
  171. A Larynx Best Preserved, but by Radiation or Formalin?
    Yom SS| | PubMed
  172. Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer?
    Boreta L, Yom SS| | PubMed
  173. Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part I: carcinoma of non-nasopharyngeal sites.
    Chapman CH, Parvathaneni U, Yom SS| | PubMed
  174. Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma.
    Chapman CH, Parvathaneni U, Yom SS| | PubMed
  175. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
    Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA| | PubMed
  176. Respiration-Induced Intraorgan Deformation of the Liver: Implications for Treatment Planning in Patients Treated With Fiducial Tracking.
    Paulsson AK, Yom SS, Anwar M, Pinnaduwage D, Sudhyadhom A, Gottschalk AR, Chang AJ, Descovich M| | PubMed
  177. Introducing: The Red Journal Gray Zone.
    Palma DA, Yom SS, Bennett KE, Corry J, Zietman AL| | PubMed
  178. The Tonsillar Fossa Battleground.
    Yom SS| | PubMed
  179. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers.
    Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK, Expert Panel on Radiation Oncology - Head and Neck Cancer| | PubMed
  180. Is Induction Chemotherapy Needed to Select Patients for Deintensified Treatment of Human Papillomavirus-Associated Oropharyngeal Cancer?
    Yom SS| | PubMed
  181. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification.
    Pugh SL, Wyatt G, Wong RK, Sagar SM, Yueh B, Singh AK, Yao M, Nguyen-Tan PF, Yom SS, Cardinale FS, Sultanem K, Hodson DI, Krempl GA, Chavez A, Yeh AM, Bruner DW| | PubMed
  182. Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma.
    Chan JW, Parvathaneni U, Yom SS| | PubMed
  183. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.
    Karam I, Yao M, Heron DE, Poon I, Koyfman SA, Yom SS, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo JA, Lee V, Foote RL, Harter KW, Lee NY, Sahgal A, Lo SS| | PubMed
  184. Impact of Neuroradiology-Based Peer Review on Head and Neck Radiotherapy Target Delineation.
    Braunstein S, Glastonbury CM, Chen J, Quivey JM, Yom SS| | PubMed
  185. Redefining the Role of Surgical Management in the Evolving Landscape of Oropharyngeal Cancer.
    Zevallos JP, Yom SS| | PubMed
  186. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
    Yu Y, Mabray M, Silveira W, Shen PY, Ryan WR, Uzelac A, Yom SS| | PubMed
  187. Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors.
    Kiang A, Weinberg VK, Cheung KH, Shugard E, Chen J, Quivey JM, Yom SS| | PubMed
  188. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
    Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS, Expert Panel on Radiation Oncology - Head and Neck| | PubMed
  189. The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.
    Tan DS, Yom SS, Tsao MS, Pass HI, Kelly K, Peled N, Yung RC, Wistuba II, Yatabe Y, Unger M, Mack PC, Wynes MW, Mitsudomi T, Weder W, Yankelevitz D, Herbst RS, Gandara DR, Carbone DP, Bunn PA, Mok TS, Hirsch FR| | PubMed
  190. ACR Appropriateness criteria® for nasopharyngeal carcinoma.
    Saba NF, Salama JK, Beitler JJ, Busse PM, Cooper JS, Jones CU, Koyfman S, Quon H, Ridge JA, Siddiqui F, Worden F, Yao M, Yom SS, Expert Panel on Radiation Oncology-Head and Neck Cancer| | PubMed
  191. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy.
    Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa AA, George JR, Yom SS| | PubMed
  192. Xanthogranuloma in the heavily irradiated low neck in a patient with head and neck cancer.
    Singer L, Calkins SM, Horvai AE, Ryan WR, Yom SS| | PubMed
  193. Delineation of radiation therapy target volumes for cutaneous malignancies involving the ophthalmic nerve (cranial nerve V-1) pathway.
    Anwar M, Yu Y, Glastonbury CM, El-Sayed IH, Yom SS| | PubMed
  194. Xerostomia health-related quality of life: NRG oncology RTOG 0537.
    Wyatt G, Pugh SL, Wong RK, Sagar S, Singh AK, Koyfman SA, Nguyen-Tân PF, Yom SS, Cardinale FS, Sultanem K, Hodson I, Krempl GA, Lukaszczyk B, Yeh AM, Berk L| | PubMed
  195. ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
    Koyfman SA, Cooper JS, Beitler JJ, Busse PM, Jones CU, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS| | PubMed
  196. Targeting epidermal growth factor receptor for head and neck squamous cell carcinoma: still lost in translation?
    Chapman CH, Saba NF, Yom SS| | PubMed
  197. The Multidisciplinary Approach Needs to Extend Into Head and Neck Cancer Clinical Trials.
    Corry J, Yom SS| | PubMed
  198. The softer (and furrier) side of oncology.
    Yom SS| | PubMed
  199. Split-field vs extended-field intensity-modulated radiation therapy plans for oropharyngeal cancer: Which spares the larynx? Which spares the thyroid?
    Yu Y, Chen J, Leary CI, Shugard E, Yom SS| | PubMed
  200. What's New in Head and Neck Cancer: Key Findings in 2015-2016 From ECCO/ESMO, ASTRO, and the Multidisciplinary Head and Neck Cancer Symposium.
    Yom SS, Ganti AK, Dietz A| | PubMed
  201. Elective versus Therapeutic Neck Dissection in Oral Cancer.
    Fakhry C, Yom S, Gillison ML| | PubMed
  202. HPV and oropharyngeal cancer: etiology and prognostic importance.
    Yom SS| | PubMed
  203. Dose De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer: First Tracks on Powder.
    Yom SS, Gillison ML, Trotti AM| | PubMed
  204. Head and Neck Cancers, Version 1.2015.
    Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M| | PubMed
  205. Radiation treatment of head and neck cancer.
    Yom SS| | PubMed
  206. Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma.
    Raleigh DR, Algazi A, Arron ST, Neuhaus IM, Yom SS| | PubMed
  207. Consolidative radiation therapy for extensive-stage small cell lung cancer.
    Singer L, Yom SS| | PubMed
  208. Prognostic significance of hyoid bone invasion in advanced base of tongue carcinoma treated by chemoradiation.
    Heaton CM, Al-Shwaiheen F, Liu CS, Yom SS, Ryan WR| | PubMed
  209. The Limitations of Routine Magnetic Resonance Imaging for Long-Term Post-Treatment Locoregional Surveillance of Salivary Carcinoma.
    Hemmat SM, Wang SJ, Uzelac A, Yom SS, Ryan WR| | PubMed
  210. Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study.
    Wong RK, Deshmukh S, Wyatt G, Sagar S, Singh AK, Sultanem K, Nguyen-Tân PF, Yom SS, Cardinale J, Yao M, Hodson I, Matthiesen CL, Suh J, Thakrar H, Pugh SL, Berk L| | PubMed
  211. Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: insights from lung tumor patients treated with robotic radiosurgery.
    Descovich M, McGuinness C, Kannarunimit D, Chen J, Pinnaduwage D, Pouliot J, Kased N, Gottschalk AR, Yom SS| | PubMed
  212. Reply to D. Adkins et al.
    Axelrod RS, Sherman E, Garden A, Nguyen-Tan PF, Trotti A, Yom SS, Zhang Q| | PubMed
  213. The advantages and drawbacks of routine magnetic resonance imaging for long-term post-treatment locoregional surveillance of oral cavity squamous cell carcinoma.
    Al-Shwaiheen FA, Wang SJ, Uzelac A, Yom SS, Ryan WR| | PubMed
  214. Molecular determinants of radiation response in non-small cell lung cancer.
    Yom SS, Diehn M, Raben D| | PubMed
  215. Accelerated repopulation as a cause of radiation treatment failure in non-small cell lung cancer: review of current data and future clinical strategies.
    Yom SS| | PubMed
  216. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
    Chyan A, Chen J, Shugard E, Lambert L, Quivey JM, Yom SS| | PubMed
  217. Development of a chemoradiation therapy toxicity staging system for oropharyngeal carcinoma.
    Goepfert RP, Yom SS, Ryan WR, Cheung SW| | PubMed
  218. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
    Kannarunimit D, Descovich M, Garcia A, Chen J, Weinberg V, Mcguinness C, Pinnaduwage D, Murnane J, Gottschalk AR, Yom SS| | PubMed
  219. Symptom management during the radiation oncology treatment course: a practical guide for the oncology clinician.
    Fogh S, Yom SS| | PubMed
  220. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.
    Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, National Comprehensive Cancer Network| | PubMed
  221. Oncology scan--nodal regions, nodal regression, and molecular biomarkers: new thinking in head and neck radiation therapy.
    Thariat J, Yom SS, Sanguineti G, Corry J| | PubMed
  222. Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.
    Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS| | PubMed
  223. Divergent management strategies for typical versus atypical carcinoid tumors of the thoracic cavity.
    Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S, Yom SS| | PubMed
  224. ACR Appropriateness Criteria® thyroid carcinoma.
    Salama JK, Golden DW, Yom SS, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Smith RV, Worden F, Yeung AR, Beitler JJ| | PubMed
  225. The ACR appropriateness criteria® for thyroid carcinoma: searching for consensus in a rapidly evolving area.
    Yom SS, Cohen E| | PubMed
  226. Multidisciplinary management of advanced basal cell carcinoma: report of four cases.
    Yu J, Aldabagh B, Wang J, Yom SS, El-Sayed I, Knott D, McGrath MH, Arron S, UCSF High Risk Skin Cancer Program| | PubMed
  227. Q&A with Dr Jay S. Cooper about Radiation Therapy Oncology Group 9003.
    Cooper JS, Yom SS| | PubMed
  228. National trends in surgery for sinonasal malignancy and the effect of hospital volume on short-term outcomes.
    Ouyang D, El-Sayed IH, Yom SS| | PubMed
  229. Improved outcomes in adjuvant radiotherapy for oral cavity carcinoma at an academic center: a matched-pair analysis.
    George JR, Yom SS, Wang SJ| | PubMed
  230. Evaluation of ray tracing and Monte Carlo algorithms in dose calculation and clinical outcomes for robotic stereotactic body radiotherapy of lung cancers.
    Braunstein SE, Dionisio SA, Lometti MW, Pinnaduwage DS, Chuang CF, Yom SS, Gottschalk AR, Descovich M| | PubMed
  231. Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis.
    Chainani-Wu N, Chang C, Gross AJ, Yom SS, Silverman S| | PubMed
  232. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
    George JR, Yom SS, Wang SJ| | PubMed
  233. American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer.
    Ridge JA, Lawson J, Yom SS, Garg MK, McDonald MW, Quon H, Saba N, Salama JK, Smith RV, Worden F, Yeung AR, Beitler JJ| | PubMed
  234. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.
    Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M, National Comprehensive Cancer Network| | PubMed
  235. Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancer.
    Garg MK, Ridge JA, Yom SS, McDonald MW, Quon H, Smith RV, Yeung AR, Lawson J, Saba N, Salama JK, Beitler JJ| | PubMed
  236. Genotype-dependent cooperation of ionizing radiation with BRAF inhibition in BRAF V600E-mutated carcinomas.
    Dasgupta T, Haas-Kogan DA, Yang X, Olow A, Yang DX, Gragg A, Orloff LA, Yom SS| | PubMed
  237. Oncology scan--head and neck cancers.
    Yom SS| | PubMed
  238. Computer-assisted, atlas-based segmentation for target volume delineation in whole pelvic IMRT for prostate cancer.
    Pejavar S, Yom SS, Hwang A, Speight J, Gottschalk A, Hsu IC, Roach M, Xia P| | PubMed
  239. Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors.
    Saba NF, Yom SS, Haigentz M, El-Rayes B| | PubMed
  240. The residual setup errors of different IGRT alignment procedures for head and neck IMRT and the resulting dosimetric impact.
    Graff P, Kirby N, Weinberg V, Chen J, Yom SS, Lambert L, Pouliot J| | PubMed
  241. EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab.
    Kono SA, Haigentz M, Yom SS, Saba N| | PubMed
  242. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.
    Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK| | PubMed
  243. SU-E-J-84: Investigating the Use of Deformable Algorithms to Register and Accumulate Dose to the Spinal Cord for Head-And-Neck Radiotherapy Patients.
    Ueda U, Chen J, Kirby N, Quivey J, Yom S, Pouliot J| | PubMed
  244. One size does not fit all lung cancer patients.
    Yom SS, Chen CP, Jahan TM, Jablons DM| | PubMed
  245. ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil.
    Expert Panel on Radiation Oncology--Head & Neck Cancer:, Yeung AR, Garg MK, Lawson J, McDonald MW, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yom SS, Beitler JJ, American College of Radiology| | PubMed
  246. Does IGRT ensure target dose coverage of head and neck IMRT patients?
    Graff P, Hu W, Yom SS, Pouliot J| | PubMed
  247. Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.
    Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS| | PubMed
  248. Diagnosis of Bilateral Tonsil Cancers via Staging PET/CT: Case Report and Review.
    Mannina EM, Pejavar SM, Glastonbury CM, van Zante A, Wang SJ, Yom SS| | PubMed
  249. Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer.
    Yom SS, Garden AS, Staerkel GA, Ginsberg LE, Morrison WH, Sturgis EM, Rosenthal DI, Myers JN, Edeiken-Monroe BS| | PubMed
  250. ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck.
    Expert Panel on Radiation Oncology-Head and Neck, Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ| | PubMed
  251. ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancer.
    McDonald MW, Lawson J, Garg MK, Quon H, Ridge JA, Saba N, Salama JK, Smith RV, Yeung AR, Yom SS, Beitler JJ, Expert Panel on Radiation Oncology-Head and Neck Cancer| | PubMed
  252. Stepwise regional and distant progression of recurrent pleomorphic adenoma.
    Chen CP, Wang SJ, van Zante A, Yom SS| | PubMed
  253. Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma.
    Kangelaris GT, Yom SS, Huang K, Wang SJ| | PubMed
  254. ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomas.
    Quon H, Yom SS, Garg MK, Lawson J, McDonald MW, Ridge JA, Saba N, Salama J, Smith R, Yeung AR, Beitler JJ| | PubMed
  255. Comparison of patient megavoltage cone beam CT images acquired with an unflattened beam from a carbon target and a flattened treatment beam.
    Faddegon BA, Aubin M, Bani-Hashemi A, Gangadharan B, Gottschalk AR, Morin O, Sawkey D, Wu V, Yom SS| | PubMed
  256. Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer.
    Tsuji SY, Hwang A, Weinberg V, Yom SS, Quivey JM, Xia P| | PubMed
  257. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy.
    Park CC, Yom SS, Podgorsak MB, Harris E, Price RA, Bevan A, Pouliot J, Konski AA, Wallner PE, Electronic Brachytherapy Working Group| | PubMed
  258. A diamond target for megavoltage cone-beam CT.
    Sawkey D, Lu M, Morin O, Aubin M, Yom SS, Gottschalk AR, Bani-Hashemi A, Faddegon BA| | PubMed
  259. Patterns of regional recurrence after definitive radiotherapy for cervical cancer.
    Beadle BM, Jhingran A, Yom SS, Ramirez PT, Eifel PJ| | PubMed
  260. Dose recalculation and the Dose-Guided Radiation Therapy (DGRT) process using megavoltage cone-beam CT.
    Cheung J, Aubry JF, Yom SS, Gottschalk AR, Celi JC, Pouliot J| | PubMed
  261. Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT?
    Hwang AB, Bacharach SL, Yom SS, Weinberg VK, Quivey JM, Franc BL, Xia P| | PubMed
  262. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
    Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z| | PubMed
  263. Assessment of carotid artery dose in the treatment of nasopharyngeal cancer with IMRT versus conventional radiotherapy.
    Vitolo V, Millender LE, Quivey JM, Yom SS, Schechter NR, Jereczek-Fossa BA, Milani F, Orecchia R, Xia P| | PubMed
  264. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.
    Huang K, Xia P, Chuang C, Weinberg V, Glastonbury CM, Eisele DW, Lee NY, Yom SS, Phillips TL, Quivey JM| | PubMed
  265. Sci-Thurs PM: Delivery-12: Correction and calibration of megavoltage cone-beam CT images for the calculation of the dose of the day.
    Aubry JF, Cheung J, Yom S, Gottschalk A, Aubin M, Morin O, Descovich M, Beaulieu L, Pouliot J| | PubMed
  266. Field-in-field technique with intrafractionally modulated junction shifts for craniospinal irradiation.
    Yom SS, Frija EK, Mahajan A, Chang E, Klein K, Shiu A, Ohrt J, Woo S| | PubMed
  267. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R| | PubMed
  268. Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer.
    Yom SS, Morrison WH, Ang KK, Rosenthal DI, Perkins GH, Wong PF, Garden AS| | PubMed
  269. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites.
    Yom SS, Rosenthal DI, El-Naggar AK, Kies MS, Hessel AC| | PubMed
  270. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
    Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI| | PubMed
  271. Genetic analysis of sinonasal adenocarcinoma phenotypes: distinct alterations of histogenetic significance.
    Yom SS, Rashid A, Rosenthal DI, Elliott DD, Hanna EY, Weber RS, El-Naggar AK| | PubMed
  272. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
    Yom SS, Rosenthal DI| | PubMed
  273. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience.
    de Crevoisier R, Ammor A, Court B, Wibault P, Chirat E, Fizazi K, Theodore C, Yom SS, Haie-Meder C| | PubMed
  274. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy.
    Yom SS, Busch TM, Friedberg JS, Wileyto EP, Smith D, Glatstein E, Hahn SM| | PubMed
  275. A phase I study of SPI-077 (Stealth liposomal cisplatin) concurrent with radiation therapy for locally advanced head and neck cancer.
    Rosenthal DI, Yom SS, Liu L, Machtay M, Algazy K, Weber RS, Weinstein GS, Chalian AA, Mille LK, Rockwell K, Tonda M, Schnipper E, Hershock D| | PubMed